AstraZeneca PLC is 69.0x more valuable than Tango Therapeutics, Inc. by market capitalization ($286.27 B vs $4.15 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TNGX | AZN |
|---|---|---|
| Market cap | $4.15 B | $286.27 B |
| US-listed rank | #1540 | #45 |
| Revenue (latest FY) | $62.38M | - |
| Net income (latest FY) | -$101.60M | - |
| Net margin | -162.9% | - |
| SEC filings | 382 | 1,002 |
AstraZeneca PLC is 69.0x more valuable than Tango Therapeutics, Inc. by market capitalization ($286.27 B vs $4.15 B).
Full pages: Tango Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.